Dr Paul Pharoah discusses research assessing genetic material from several hundred cancer patients across world. This study has identified many new genetic sub-types associated with breast, ovarian and prostate cancer risk and has many potential clinical benefits such as improvements in the effectiveness of breast or prostate cancer screening programmes or the identification of new targets for personalised medicines.